Author:
Kuck N.A.,Petersen P.J.,Weiss W.J.,Testa R.T.
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Reference8 articles.
1. Micetich RG, Hall TW, Maiti SH, et al. The YTR class of β-lactamase inhibitors. In J. Ishigami, ed. «Recent Adv Chemother. Proc. 14th Int. Congr. Chemother. Kyoto». Antimicrobial Sect. 1, Tokyo: University of Tokyo Press, 1985: 249–250.
2. Gutmann L, Kitzis MD, Yamabe S, Acar JF. Comparative evaluation of a new β-lactamase inhibitor, YTR 830, combined with different β-lactam antibiotics against bacteria harboring known β-lactamases. Antimicrob Agents Chemother 1986; 29: 955–957.
3. Appelbaum PC, Jacobs MR, Spangler S, Yamabe S. Comparative activity of β-lactamase inhibitors YTR-830, clavulanate, and sulbactam combined with β-lactams against β-lactamase producing anaerobes. Antimicrob Agents Chemother 1986; 30: 789–791.
4. Aronoff SC, Jacobs MR, Johenning J, Yamabe S. Comparative activities of the β-lactamase inhibitors YTR 830, sodium clavulanate and sulbactam combined with amoxicillin or ampicillin. Antimicrob Agents Chemother 1984; 26: 580–582.
5. Aronoff SC, Jacobs MR, Labrozzi PH, Yamabe S. Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice. J Antimicrob Chemother 1986; 18: 271–276.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献